Crohn's Disease Clinical Trials in Tampa, Florida

8 studies are recruiting for crohn's disease in Tampa, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of SL-325 in Crohn's Disease Patients

   The primary purpose of this study is to evaluate the efficacy of SL-325 in adult participants with moderate to severely active Crohn's disease. The study consists of a screening period of up to 6 weeks, a 12-week induction period, 38-week maintenance period, 52-week long-term extension period, and …

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   Clinical Trial Site, Tampa, Florida

   Locations

   20 in total

   Run by

   Shattuck Labs, Inc.

   See if you can join NCT07753850 on ClinicalTrials.gov

2. A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

   Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study i…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   USF Health Morsani Center for Advanced Healthcare, Tampa, Florida

   Locations

   201 in total

   Run by

   Takeda

   See if you can join NCT06233461 on ClinicalTrials.gov

3. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

   The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinica…

   Stage

   Phase 3

   Ages

   16 to 80

   Site

   USF Health Carol and Frank Morsani Center for Advanced Healthcare ( Site 5039), Tampa, Florida

   Locations

   499 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06430801 on ClinicalTrials.gov

4. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

   Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, severe inflammation (redness, swelling) in the digestive tract. CD can affect any part of the digestive tract causing many different symptoms including belly pain, diarrhea, tiredne…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Gcp Clinical Research /ID# 280469, Tampa, Florida

   Locations

   66 in total

   Run by

   AbbVie

   See if you can join NCT07697456 on ClinicalTrials.gov

5. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

   This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active CD. Study details include: The study duration may be up to 35 …

   Stage

   Phase 3

   Ages

   16 to 80

   Site

   NMC Research LLC-Site Number: 8400033, Tampa, Florida

   Locations

   461 in total

   Run by

   Sanofi

   See if you can join NCT07184931 on ClinicalTrials.gov

6. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

   This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease (CD). Study details include: The study duration may be up to 286 weeks including: * 40-…

   Stage

   Phase 3

   Ages

   16 to 80

   Site

   NMC Research LLC-Site Number: 8400033, Tampa, Florida

   Locations

   109 in total

   Run by

   Sanofi

   See if you can join NCT07184944 on ClinicalTrials.gov

7. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

   Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms including belly pain, diarrhea, tiredness, and weight loss. Treatments are available but do not work…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Gcp Clinical Research /ID# 278126, Tampa, Florida

   Locations

   255 in total

   Run by

   AbbVie

   See if you can join NCT06548542 on ClinicalTrials.gov

8. A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

   The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel inflammation and ulcers in the bowel compared to vedolizumab only (also called monotherapy) in adults with moderately or severely active Crohn's Diseas…

   Stage

   Phase 3

   Ages

   18 to 65

   Site

   USF Health Morsani Center for Advanced Healthcare, Tampa, Florida

   Locations

   138 in total

   Run by

   Takeda

   See if you can join NCT06227910 on ClinicalTrials.gov